Finerenone's FDA approval marks a breakthrough in heart failure treatment, significantly reducing cardiovascular events and hospitalizations for patients.
RX Review: Updates and Unmet Needs in HFmrEF/HFpEF—The Role of Finerenone
Finerenone's FDA approval marks a transformative step in heart failure treatment, offering early benefits and broad applicability.
Panelists offer perspective on the role of finerenone in combination therapy approaches in patients with HFmrEF/HFpEF.
Panelists discuss differentiators between nsMRA and steroidal MRAs in the context of heart failure.
Advertisement
Advertisement
Trending on HCPLive
1
First Half 2026 Recap: Dermatology
2
From Red-Cheeked Baby to Bulbous Nose: Rosacea, Start to Finish
3
Guideline-Directed Care Improves Limb Outcomes in Peripheral Artery Disease
4
Navigating a New Era of PH Management as an APP, With Susanne McDevitt, DNP
5